Regeneron Pharmaceuticals, Inc.
Mitochondrial DNA Quality Control

Last updated:

Abstract:

The present disclosure provides methods of identifying unreliable biological samples that may be mislabeled or contaminated, by determining the heteroplasmy and homoplasmy of mitochondrial DNA present in the biological samples.

Status:
Application
Type:

Utility

Filling date:

6 Aug 2021

Issue date:

10 Feb 2022